3M, Hawaiian Electric stocks surge, Novocure shares plunge and other stocks on the move
By MarketWatch
XPeng shares rise on deal news
Here are some of Monday's bigger and more-active movers:
Stock gainers
Hawaiian Electric Industries Inc.'s stock (HE) rocketed 36% in morning trading, a day after closing at a 39-year low, after the electric company called a lawsuit by Maui County over the deadly Lahaina fires "factually and legally irresponsible."
Shares of 3M Co. (MMM) rose 3.7%, enough to pace the Dow Jones Industrial Average's DJIA gainers, after The Wall Street Journal reported that the multinational conglomerate was nearing agreement on a $5.5 billion plan to settle more than 300,000 lawsuits over defective military earplugs.
XPeng Inc. (XPEV) stock climbed 2.4% after the China electric vehicle maker announced a strategic partnership with mobile tech platform DiDi Global Inc. (DIDIY), buying its smart auto development business DiDi's U.S.-listed shares gained 2.8%.
Hersha Hospitality Trust shares (HT) ran up 56% toward a record one-day gain after the real-estate investment trust focused on the hospitality sector announced an agreement to be acquired by private-equity firm KSL Capital Partners LLC in a cash deal valued at $1.4 billion.
Thorne HealthTech Inc.'s stock THRN rallied 29% after the wellness company said it agreed to be taken private by L Catterton for $10.20 a share in cash in a deal valued at $680 million.
Shares of Horizon Therapeutics PLC(HZNP) climbed 6% after the Federal Trade Commission paused its legal challenge to Amgen Inc.'s deal to acquire the biotech company for $27.8 billion.
RPT Realty's stock (RPT) hiked up 19% after the New York-based shopping center owner announced an agreement to be acquired by Kimco Realty Corp. in an all-stock deal valued at $2 billion including debt. Kimco's stock (KIM) gained 1.2%.
BrightView Holdings Inc. shares (BV) got an 11% boost after the commercial landscaping services company said it received a $500 million investment from private-equity firm Rock Capital Partners LLC.
GD Culture Group Ltd. shares (GDC) shot up 64% after the Hong Kong-based small-capitalization company said it plans to enter the live-streaming e-commerce business launched on the social-media platform TikTok.
Stock decliners
Shares of Novocure Ltd. (NVCR) plummeted 33% toward a five-year low after the oncology company said a late-stage trial of its ovarian cancer treatment failed to meet its primary endpoint.
CrowdStrike Holdings Inc.'s stock (CRWD) dropped 2.4% after the cybersecurity company was downgraded to equal weight from overweight at Morgan Stanley, citing signs of a further industry slowdown and cloud optimization headwinds.
ImmunoGen Inc. shares (IMGN) shed 6.5%, to reverse an earlier premarket gain, after the Massachusetts-based drugmaker announced a collaboration with Takeda Pharmaceutical Co. Ltd. (4502.TO) to commercialize its Elahere ovarian cancer treatment in Japan.
-MarketWatch
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-28-23 1156ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track